ICAM-1 Targeted Drug Combination Nanoparticles Enhanced Gemcitabine-Paclitaxel Exposure and Breast Cancer Suppression in Mouse Models

ICAM-1 Targeted Drug Combination Nanoparticles Enhanced Gemcitabine-Paclitaxel Exposure and Breast Cancer Suppression in Mouse Models

Despite the availability of molecularly targeted treatments such as antibodies and small molecules for human epidermal growth factor receptor 2 (HER2), hormone receptor (HR), and programmed death-ligand 1 (PD-L1), limited treatment options are available for advanced metastatic breast cancer (MBC), w...

Full description

Bibliographic Details
Main Authors:	Linxi Zhu, Qingxin Mu, Jesse Yu, James I. Griffin, Xiaolin Xu, Rodney J. Y. Ho
Format:	Article
Language:	English
Published:	MDPI AG 2021-12-01
Series:	Pharmaceutics
Subjects:	metastatic breast cancer nanoparticles ICAM-1 targeting combination therapy
Online Access:	https://www.mdpi.com/1999-4923/14/1/89

Similar Items

ICAM-1 and ICAM-2 Are Differentially Expressed and Up-Regulated on Inflamed Pulmonary Epithelium, but Neither ICAM-2 nor LFA-1: ICAM-1 Are Required for Neutrophil Migration Into the Airways In Vivo
by: Deborah L. W. Chong, et al.
Published: (2021-08-01)

ICAM-1-related long non-coding RNA: promoter analysis and expression in human retinal endothelial cells
by: Amanda L. Lumsden, et al.
Published: (2018-05-01)

ICAM-1 and S100β plasma value in children with sepsis
by: Lisa Safira, et al.
Published: (2020-06-01)

ICAM-1 Kilifi variant is not associated with cerebral and severe malaria pathogenesis in Beninese children
by: Samuel Odarkwei Blankson, et al.
Published: (2022-04-01)

MMI-0100 ameliorates lung inflammation in a mouse model of acute respiratory distress syndrome by reducing endothelial expression of ICAM-1
by: He B, et al.
Published: (2018-12-01)

A Survey of interval training on the expression of ICAM, VCAM and galectin-3 proteins in the heart tissue of asthmatic rats
by: Masome Nobahar, et al.
Published: (2021-10-01)

Targeting sites of inflammation:Intercellular adhesion molecule-1 (ICAM-1) as a target for novel inflammatory therapies
by: Susan eHua
Published: (2013-10-01)

Reduction of Endothelial Nitric Oxide Increases the Adhesiveness of Constitutive Endothelial Membrane ICAM-1 through Src-Mediated Phosphorylation
by: Feng Gao, et al.
Published: (2018-01-01)

ICAMs in Immunity, Intercellular Adhesion and Communication
by: Claudia Guerra-Espinosa, et al.
Published: (2024-02-01)

ICAM3-Fc Outperforms Receptor-Specific Antibodies Targeted Nanoparticles to Dendritic Cells for Cross-Presentation
by: Luis J. Cruz, et al.
Published: (2019-05-01)

ICAM-1 molecular mechanism and genome wide SNP's association studies
by: C. Anbarasan, et al.
Published: (2015-05-01)

Intercellular Adhesion Molecule-1 (ICAM-1) and ICAM-2 Differentially Contribute to Peripheral Activation and CNS Entry of Autoaggressive Th1 and Th17 Cells in Experimental Autoimmune Encephalomyelitis
by: Neda Haghayegh Jahromi, et al.
Published: (2020-01-01)

ICAM-1-targeted and antibacterial peptide modified polymeric nanoparticles for specific combating sepsis
by: Lingling Pan, et al.
Published: (2022-10-01)

ADAM10-Mediated Cleavage of ICAM-1 Is Involved in Neutrophil Transendothelial Migration
by: Sofia K. H. Morsing, et al.
Published: (2021-01-01)

Blocking rhinoviral adhesion molecule (ICAM-1): potential to prevent COPD exacerbations
by: Shukla SD, et al.
Published: (2017-05-01)

Effect of 8-week Swimming training and garlic intake on serum ICAM and VCAM adhesion molecules in male obese rats.
by: Shahin Riyahi Malayeri, et al.
Published: (2019-01-01)

ICAM-1 expression on blood lymphocytes in patients with stromal herpes keratitis at different periods of disease
by: N.I. Khramenko, et al.
Published: (2020-01-01)

NANOG helps cancer cells escape NK cell attack by downregulating ICAM1 during tumorigenesis
by: Kotaro Saga, et al.
Published: (2019-10-01)

Generation of high affinity ICAM-1-specific nanobodies and evaluation of their suitability for allergy treatment
by: Ines Zettl, et al.
Published: (2022-11-01)

Targeting delivery of simvastatin using ICAM-1 antibody-conjugated nanostructured lipid carriers for acute lung injury therapy
by: Shu-Juan Li, et al.
Published: (2017-01-01)

Sesquiterpenes from Myrrh and Their ICAM-1 Inhibitory Activity In Vitro
by: Katrin Kuck, et al.
Published: (2020-12-01)

ICAM-1 depletion in the center of immunological synapses is important for calcium releasing in T-cells
by: Yuanzhen Suo, et al.
Published: (2018-03-01)

Serum ICAM-1 level and ICAM-1 gene 1462A>G (K469E) polimorphism on microalbuminuria in nondiabetic, nonhypertensive and normolipidemic obese patients: Genetical background of microalbuminuria in obesity
by: Ahmet Engin Atay, et al.
Published: (2017-07-01)

Serum ICAM-1 level and ICAM-1 gene 1462A>G (K469E) polimorphism on microalbuminuria in nondiabetic, nonhypertensive and normolipidemic obese patients: Genetical background of microalbuminuria in obesity
by: Ahmet Engin Atay, et al.
Published: (2017-07-01)

Uroven' v syvorotke i pochechnaya ekspressiya molekul mezhkletochnoy adgezii ICAM-1u bol'nykh s diabeticheskoy nefropatiey
by: Irina Arkad'evna Bondar', et al.
Published: (2007-09-01)

Anti-metastatic activity of Agrocybe aegerita galectin (AAL) in a mouse model of breast cancer lung metastasis
by: Qing Yang, et al.
Published: (2018-02-01)

The Relationship between Eating Disorders and ICAM-1, E-selection and Ghrelin Resting Level in Overweight People
by: Gholamreza Sharifi
Published: (2014-11-01)

Evaluation of VCAM-1 and ICAM-1 concentration and values of global tests concerning the coagulation system of patients suffering from subarachnoid haemorrage
by: Abu-Sitta Al-Drawi, et al.
Published: (2016-09-01)

ICAM-5 affects spine maturation by regulation of NMDA receptor binding to α-actinin
by: Lin Ning, et al.
Published: (2015-01-01)

ICAM-1-Targeted Liposomes Loaded with Liver X Receptor Agonists Suppress PDGF-Induced Proliferation of Vascular Smooth Muscle Cells
by: Xu Huang, et al.
Published: (2017-05-01)

The Combination of Anlotinib and Gemcitabine/Docetaxel in Patients with Metastatic Osteosarcoma Who Have Failed Standard Chemotherapy
by: Wang T, et al.
Published: (2022-10-01)

Maprotiline inhibits LPS-induced expression of adhesion molecules (ICAM-1 and VCAM-1) in human endothelial cells
by: Laleh Rafiee, et al.
Published: (2016-01-01)

Quercetin nanoparticle complex attenuated diabetic nephropathy via regulating the expression level of ICAM-1 on endothelium
by: Tong F, et al.
Published: (2017-10-01)

Effect of PLGA-IB on ICAM-1 and VCAM-1 expression in a mice adhesion model
by: Fatemeh Jamshidi-Adegani, et al.
Published: (2016-07-01)

Mesenchymal Stromal Cells Rapidly Suppress TCR Signaling-Mediated Cytokine Transcription in Activated T Cells Through the ICAM-1/CD43 Interaction
by: Shuwei Zheng, et al.
Published: (2021-02-01)

The Effects of Combination of High Intensity Intermittent Exercise and Supplement Flaxseed Oil 1 ICAM- Plasma Concentration in Male Rats
by: Y Khademi, et al.
Published: (2017-01-01)

Porphyromonas gingivalis W83 traffics via ICAM1 in microvascular endothelial cells and alters capillary organization in vivo
by: L. Reyes, et al.
Published: (2020-01-01)

Exploring the Roles of Vitamins C and D and Etifoxine in Combination with Citalopram in Depression/Anxiety Model: A Focus on ICAM-1, SIRT1 and Nitric Oxide
by: Omar Gammoh, et al.
Published: (2024-02-01)

Role of ICAM1 in tumor immunity and prognosis of triple-negative breast cancer
by: Qin Zhou, et al.
Published: (2023-08-01)

Tuning Design Parameters of ICAM-1-Targeted 3DNA Nanocarriers to Optimize Pulmonary Targeting Depending on Drug Type
by: Nikša Roki, et al.
Published: (2022-07-01)